Rede Nordeste de Biotecnologia, Programa de Pós-Graduação em Biotecnologia, Universidade Estadual do Ceará, Campus do Itaperi, Fortaleza, Ceará, Brasil. Laboratório de Biotecnologia e Biologia Molecular, Universidade Estadual do Ceará, Campus do Itaperi, Fortaleza, Ceará, Brasil. image/svg+xml
Auto-generated profile, based on publicly available information
Natália Do Vale Canabrava
Rede Nordeste de Biotecnologia, Programa de Pós-Graduação em Biotecnologia, Universidade Estadual do Ceará, Campus do Itaperi, Fortaleza, Ceará, Brasil. Laboratório de Biotecnologia e Biologia Molecular, Universidade Estadual do Ceará, Campus do Itaperi, Fortaleza, Ceará, Brasil. image/svg+xml
Diabetes mellitus is one of the most common chronic degenerative diseases, and it is estimated to increase worldwide to around 415 million and to impact 642 million in 2040. Research shows that some plants are sources of bioactive compounds against diabetes. Thus, the objective of this work was to evaluate the oral toxicity and the hypoglycemic effect of the aqueous extract of the leaves of Cnidoscolus quercifolius Pohl. Diabetes was induced in Swiss mice with streptozotocin and the mice were treated with an aqueous extract of C. quercifolius leaves for a period of 30 days. Phytochemical analysis showed that the extract was rich in flavonoids, catechins and triterpenoid, which did not show any mortality and behavioral alterations in mice treated with 200, 1000, and 2000 mg/kg body weight of the extract for 14 days. Histopathological analysis of organs (kidney, pancreas, liver) from mice treated with the 2000 mg/kg extract revealed no architectural change. In the present study, we found a 29% reduction in glucose levels in animals receiving 200 mg/kg body weight. These results are very promising because they showed that C. quercifolius had a hypoglycemic effect and did not present oral toxicity, thus being a new source of compounds for the control of diabetes.
17 September 2020 in Research, Society and Development
Objetivo: realizar uma revisão integrativa sobre a função dos prebióticos e probióticos na manutenção da saúde, bem como suas aplicações no tratamento da constipação idiopática crônica (CIC), da síndrome do intestino irritável (SII) e da doença inflamatória intestinal (DII). Metodologia: trata-se de uma revisão integrativa da literatura, cuja busca dos estudos foi realizada nas bases de dados Cochrane e PubMed, com análise de trabalhos publicados nos últimos dez anos (2010-2020) escritos em inglês. Resultados: O uso de probióticos na CIC e SII mostrou efeitos benéficos na redução dos sintomas dessas doenças, modificação na microbiota e melhora na qualidade de vida dos pacientes. Na CIC, a inulina foi o prebiótico com mais efeitos positivos na sintomatologia da doença. Na DII, o uso de prebióticos e probióticos mostrou efeitos benéficos discretamente maiores para a RCU do que para a DC. Conclusão: Prebióticos e probióticos podem trazer tanto benefícios preventivos quanto terapêuticos à saúde intestinal, com ações diretas e indiretas na microbiota, imunidade e processos metabólicos do hospedeiro. A utilização desses compostos e microrganismos nas doenças estudadas demonstram resultados promitentes, principalmente, no campo dos probióticos. A partir da análise dos ensaios clínicos, as cepas promissoras no tratamento da DII foram Bifidobacterium, Lactobacillus, Enterococcus faecium (DC e RCU) e Clostridium butyricum (RCU). No entanto, salientamos a necessidade de estudos mais homogêneos no tratamento da DC com probióticos e prebióticos e o uso de prebióticos na SII.
11 November 2015 in Diabetology & Metabolic Syndrome
P-methoxycinnamic diesters from carnauba wax powder (PCO - C) – cinnamic acid derivate – have been associated with new properties such as hypolipidemic, hypocholesterolemic and hypoglycaemic effects in mice. The present study aimed to investigate the safety profile of PCO - C by evaluating the subchronic oral toxicity, genotoxicity and mutagenicity using in vivo experimental models. Therefore, for the present research, characterized as experimental and of a quantitative nature, 80 Swiss mice, of both genders, were used for the analysis of mutagenicity, genotoxicity, analysis of the biochemical, hematological and toxicological profiles. PCO - C did not induce changes in the mass of animals besides not interfering in blood parameters. PCO - C showed no hemolysis of mouse erythrocytes. PCO - C caused no mutagenic or genotoxic effects in male and female mice treated with 500 mg/Kg/day during 90 days. In addition, PCO - C did not change some important serum parameters (alanine aminotransferase, aspartate aminotransferase, total cholesterol and creatinine), hematological profile, structural arrangement of the kidneys, heart, stomach and spleen. The results demonstrate that PCO - C is not genotoxic, and did not present toxicity when used orally for up to 90 days. Overall, the study has demonstrated the safety of PCO - C for potential uses in biomedical areas.
Occupational exposure to infectious bronchitis virus (IBV) has been associated with cross‐reactivity to other coronaviruses such as SARS‐CoV‐2. In this study, we investigated the immune response of IBV using reconstituted samples of the commercial H120 Mass‐I vaccine (Zoetis) against SARS‐CoV‐2 infection. Bioinformatics analyses, serological assays, and neutralization tests were conducted to evaluate the neutralizing capacity of anti‐IBV antibodies against SARS‐CoV‐2 in serum samples from poultry farm workers exposed to the IBV‐H120 vaccine. Mouse immunization assays and flow cytometry analysis were conducted to characterize the immune response triggered by IBV‐H120. Finally, a histological analysis of the lungs of Syrian hamsters vaccinated with IBV and challenged with SARS‐CoV‐2 (Wuhan and Delta strains) was conducted to evaluate the protective potential of the vaccine. Neutralizing antibodies against IBV‐H120 were detected in the serum of poultry farm workers, indicating cross‐reactivity with SARS‐CoV‐2. The immune response in mice immunized with IBV‐H120 demonstrated that only the intranasal and oral routes were effective against SARS‐CoV‐2. An increase in the percentage of CD19 + induced by IBV‐H120 vaccination was demonstrated by flow cytometry. Intranasal administration of the IBV‐H120 vaccine reduced lung damage in Syrian hamsters against the Wuhan and Delta variants of SARS‐CoV‐2. IBV‐H120 elicited both humoral and cellular immune responses in mice and reduced lung damage in hamsters challenged with the Wuhan and Delta variants. This indicates that it could be an improved vaccine for controlling SARS‐CoV‐2.
1 September 2026 in Revista de Epidemiologia e Controle de Infecção
Background and Objectives: Dengue is a viral disease transmitted by the Aedes aegypti mosquito, characterized by rapid spread and global impact. In addition to dengue, this vector transmits Zika and Chikungunya viruses. Given the limited availability of antiviral therapies, the development of new treatments is critical. Chalcone compounds have demonstrated both larvicidal and antiviral potential, making them promising candidates in the fight against these diseases. This study aims to conduct a literature review on the therapeutic potential of chalcones in combating dengue, using bibliometric analysis. Content: The bibliometric analysis was performed using the Scopus database to identify both global and national publications. Data collection involved Boolean search strategies and specific filters, and the retrieved documents were analyzed using the Bibliometrix tool to assess key research trends, collaboration networks, and Brazil’s contribution to the field. The analysis highlights the main research domains, author contributions, institutional affiliations, and publication trends by country. By examining publications from 2006 to 2024, the study identifies the most prominent research areas, leading authors, influential journals, and country-specific contributions. Conclusion: The findings reveal a growing body of scientific literature on chalcones and dengue, with pioneering studies underscoring their antiviral potential. The study also maps global collaboration networks, contributing to advances in antiviral discovery and vector control.